Cargando…
High-throughput analysis of the RNA-induced silencing complex in myotonic dystrophy type 1 patients identifies the dysregulation of miR-29c and its target ASB2
Myotonic dystrophy type 1 (DM1) is a multi-systemic disorder caused by abnormally expanded stretches of CTG DNA triplets in the DMPK gene, leading to mutated-transcript RNA-toxicity. MicroRNAs (miRNAs) are short non-coding RNAs that, after maturation, are loaded onto the RISC effector complex that d...
Autores principales: | Cappella, Marisa, Perfetti, Alessandra, Cardinali, Beatrice, Garcia-Manteiga, Jose Manuel, Carrara, Matteo, Provenzano, Claudia, Fuschi, Paola, Cardani, Rosanna, Renna, Laura Valentina, Meola, Giovanni, Falcone, Germana, Martelli, Fabio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023919/ https://www.ncbi.nlm.nih.gov/pubmed/29955039 http://dx.doi.org/10.1038/s41419-018-0769-5 |
Ejemplares similares
-
Dysregulation of Circular RNAs in Myotonic Dystrophy Type 1
por: Voellenkle, Christine, et al.
Publicado: (2019) -
CRISPR/Cas9-Mediated Deletion of CTG Expansions Recovers Normal Phenotype in Myogenic Cells Derived from Myotonic Dystrophy 1 Patients
por: Provenzano, Claudia, et al.
Publicado: (2017) -
Deregulated MicroRNAs in Myotonic Dystrophy Type 2
por: Greco, Simona, et al.
Publicado: (2012) -
Genome Wide Identification of Aberrant Alternative Splicing Events in Myotonic Dystrophy Type 2
por: Perfetti, Alessandra, et al.
Publicado: (2014) -
Molecular Therapies for Myotonic Dystrophy Type 1: From Small Drugs to Gene Editing
por: Izzo, Mariapaola, et al.
Publicado: (2022)